Tanuxiciclib (trihydrochloride)
Tanuxiciclib trihydrochloride is a cyclin dependent kinase (CDK) inhibitor[1].
Product Specifications
CAS Number
[1983984-11-7]
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/tanuxiciclib-trihydrochloride.html
Purity
98.0
Solubility
DMSO : 3.33 mg/mL (ultrasonic)
Smiles
FC1=C(C2=CC=C(O)C(C3=CC(C)=NC(N)=N3)=N2)C=CN=C1N.Cl.Cl.Cl
Molecular Formula
C15H16Cl3FN6O
Molecular Weight
421.68
References & Citations
[1]International Nonproprietary Names for Pharmaceutical Substances (INN) . WHO Drug Information, Vol. 35, No. 4, 2021.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
